This ADC product is comprised of an anti-CD22 monoclonal antibody (clone 10F4v3) conjugated via a Mc-VC-PABC linker to MMAE. The MMAE is targeted to certain cancers by immunerecognition and delivered …
This ADC product is comprised of an anti-CD22 monoclonal antibody (clone 10F4v3) conjugated via a Mc linker to MMAF. The MMAF is targeted to certain cancers by immunerecognition and delivered into can…
http://www.creative-biolabs.com/adc/target-cd22-10.htmThis ADC product is comprised of an anti-CD22 monoclonal antibody (clone 10F4v3) conjugated via a BMPEO linker to DM1. The DM1 is targeted to cert…
This ADC product is comprised of an anti-CD22 monoclonal antibody conjugated (clone hLL2) via a linker to SN-38. The SN-38 is targeted to certain cancers by immunerecognition and delivered …
This ADC product is comprised of an anti-CD19 monoclonal antibody (B496) conjugated via a Mc linker to MMAF. The MMAF is targeted to certain cancers by immunerecognition and delivered into cancer cell…
This ADC product is comprised of an anti-CD19 monoclonal antibody (B496) conjugated via a Mc-VC-PABC linker to MMAE. The MMAE is targeted to certain cancers by immunerecognition and delivered into can…
This ADC product is comprised of an anti-CD19 monoclonal antibody (B496) conjugated via a MCC linker to DM1. The DM1 is targeted to certain cancers by immunerecognition and delivered into cancer cells…
This ADC product is comprised of an anti-CD19 monoclonal antibody (B496) conjugated via a SPP linker to DM1. The DM1 is targeted to certain cancers by immunerecognition and delivered into cancer cells…
This ADC product is comprised of an anti-CD19 monoclonal antibody (MDX1435) conjugated via a VC linker to duocarmycin. The duocarmycin is targeted to certain cancers by immunerecognition and delivered…
This ADC product is comprised of an anti-CD19 monoclonal antibody (MDX1435) conjugated via a VC linker to duocarmycin. The duocarmycin is targeted to certain cancers by immunerecognition and delivered…
ECROBOT CO., Ltd, Business Registration Number : 220-88-71747, CEO J.W.Park, TEL : +82-2-552-7676, E-mail : E-mail : Contact us Address : (Hwanghwa B/D 11F, Yeoksam-dong)320, Gangnam-daero, Gangnam-gu, Seoul, South Korea